Lista de obras -

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

artículo científico publicado en 2015

A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer.

artículo científico publicado en 2004

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

artículo científico publicado en 2010

Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience

scientific article published on 01 November 2019

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma

artículo científico publicado en 2003

Continuation of trastuzumab beyond disease progression

artículo científico publicado en 2005

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

artículo científico publicado en 2019

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

artículo científico publicado en 2016

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

artículo científico publicado en 2015

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

artículo científico publicado en 2008

Metaplastic breast carcinoma: pathology and clinical outcome.

artículo científico publicado en 2003

Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study

artículo científico publicado en 2009

Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy

artículo científico publicado en 2006

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

artículo científico publicado en 2013

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients